Paper
25 February 2010 Review of technology development and clinical trials of transcranial laser therapy for acute ischemic stroke treatment
Brian E. Catanzaro, Jackson Streeter M.D., Luis de Taboada
Author Affiliations +
Proceedings Volume 7552, Mechanisms for Low-Light Therapy V; 75520J (2010) https://doi.org/10.1117/12.842043
Event: SPIE BiOS, 2010, San Francisco, California, United States
Abstract
Stroke is the one of the leading causes of mortality in the United States, claiming 600,000 lives each year. Evidence suggests that near infrared (NIR) illumination has a beneficial effect on a variety of cells when these cells are exposed to adverse conditions. Among these conditions is the hypoxic state produced by acute ischemic stroke (AIS). To demonstrate the impact NIR Transcranial Laser Therapy (TLT) has on AIS in humans, a series of double blind, placebo controlled clinical trials were designed using the NeuroThera(R) System (NTS). The NTS was designed and developed to treat subjects non-invasively using 808 nm NIR illumination. TLT, as it applies to stroke therapy, and the NTS will be described. The results of the two clinical trials: NeuroThera(R) Safety and Efficacy Trial 1 (NEST-1) and NeuroThera(R) Safety and Efficacy Trial 2 (NEST-2) will be reviewed and discussed.
© (2010) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Brian E. Catanzaro, Jackson Streeter M.D., and Luis de Taboada "Review of technology development and clinical trials of transcranial laser therapy for acute ischemic stroke treatment", Proc. SPIE 7552, Mechanisms for Low-Light Therapy V, 75520J (25 February 2010); https://doi.org/10.1117/12.842043
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Near infrared

Clinical trials

Animal model studies

Ischemic stroke

Binary data

Laser therapeutics

Safety

Back to Top